Form 4 for ERNA Ernexa Therapeutics Inc.
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001140361-21-041286 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-10 | 2021-06-01 | ERNA | Cherington Charles | Dir | J - Other | $0.00 | +92 | 5.89M | +0.0% | $0 |
| D | 2021-12-10 | 2021-12-08 | ERNA | Cherington Charles | Dir | A - Grant | $0.00 | +67.0K | 67.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-06-01 | J | A | 92 | $0.00 | 5,894,193 | D | — | — | (F1) Represents a stock dividend declared on shares of the Issuer's Series A Preferred Stock. |
| 2 | Derivative | Stock Option | 2021-12-08 | A | A | 67,000 | $0.00 | 67,000 | D | $5.94 · — to 2031-12-07 | 67,000 Common Stock | (F2) A total of 22,336 of the shares subject to the option vest and become exercisable as of 12:01 a.m. Eastern time on the date of the issuer's 2022 Annual Meeting of Stockholders and the remaining 44,664 shares vest and become exercisable in equal monthly installments over the following 24 months, subject to continued service through each vesting date. |